• S4 Ep3: Myfembree for moderate-to-severe endometriosis pain: Potential for adolescents

  • Mar 2 2022
  • Length: Not Yet Known
  • Podcast

  • Summary

  • Contemporary OB/GYN® Associate Editor Lindsey Carr sat down with Jessica Shim, MD, an attending at in the Division of Gynecology, Department of Surgery, Boston Children’s Hospital; Harvard Medical School Boston, Massachusetts, to discuss Myfembree (relugolix, estradiol, and norethindrone acetate tablets; Myovant Sciences, Pfizer) and its possible approval in May 2022.
    Show more Show less
activate_primeday_promo_in_buybox_DT
Show more Show less

What listeners say about S4 Ep3: Myfembree for moderate-to-severe endometriosis pain: Potential for adolescents

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com reviews

Amazon reviews
No Reviews are Available